MiMedx Group Investor Relations Material
Latest events
Q3 2024
MiMedx Group
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from MiMedx Group Inc
Access all reports
MiMedx Group Inc. is a biopharmaceutical company specializing in regenerative medicine. The company develops and markets advanced products derived from human placental tissue to support wound healing and tissue repair. MiMedx’s solutions are used in areas such as chronic wound care, surgical applications, and musculoskeletal conditions. The company is headquartered in Marietta, Georgia, and its shares are listed on the NASDAQ.
Key slides for MiMedx Group Inc
Investor Presentation
MiMedx Group Inc
Investor Presentation
MiMedx Group Inc
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
MDXG
Country
🇺🇸 United States